PharmaCielo Ltd. (TSXV:PCLO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0600
-0.0050 (-7.69%)
Apr 25, 2025, 9:30 AM EDT
-63.64%
Market Cap 12.21M
Revenue (ttm) 3.48M
Net Income (ttm) -9.14M
Shares Out 187.83M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 374,475
Open 0.0600
Previous Close 0.0650
Day's Range 0.0600 - 0.0600
52-Week Range 0.0250 - 0.2600
Beta 1.96
RSI 42.06
Earnings Date May 29, 2025

About PharmaCielo

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. The company has strategic partnership with B... [Read more]

Sector Healthcare
CEO Marc Lustig
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol PCLO
Full Company Profile

Financial Performance

In 2024, PharmaCielo's revenue was 3.48 million, an increase of 125.70% compared to the previous year's 1.54 million. Losses were -9.14 million, -43.91% less than in 2023.

Financial Statements

News

There is no news available yet.